Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.

[1][2] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.This monoclonal antibody–related article is a stub.

You can help Wikipedia by expanding it.